Lanxess AG
F:LXS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lanxess AG
F:LXS
|
DE |
|
K
|
Konsolidator A/S
CSE:KONSOL
|
DK |
|
W
|
Westwater Resources Inc
F:UCCP
|
US |
|
Dovalue SpA
MIL:DOV
|
IT |
|
T
|
Tab Gida Sanayi ve Ticaret AS
IST:TABGD.E
|
TR |
|
C
|
Canopy Holdings AS
OSE:CAN
|
NO |
|
A
|
Alset Ehome International Inc
NASDAQ:AEI
|
US |
|
H
|
Huazhu Group Ltd
NASDAQ:HTHT
|
CN |
|
MusclePharm Corp
OTC:MSLPQ
|
US |
|
R
|
Rce Capital Bhd
KLSE:RCECAP
|
MY |
|
I
|
IMC Exploration Group PLC
LSE:IMC
|
IE |
|
X
|
XBP Europe Holdings Inc
NASDAQ:XBP
|
US |
|
Delivra Health Brands Inc
XTSX:DHB
|
CA |
Wall Street
Price Targets
LXS Price Targets Summary
Lanxess AG
According to Wall Street analysts, the average 1-year price target for
LXS
is 19.47 EUR
with a low forecast of 13.76 EUR and a high forecast of 31.1 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LXS's stock price target?
Price Target
19.47
EUR
According to Wall Street analysts, the average 1-year price target for
LXS
is 19.47 EUR
with a low forecast of 13.76 EUR and a high forecast of 31.1 EUR.
What is Lanxess AG's Revenue forecast?
Projected CAGR
3%
For the last 14 years the
compound annual growth rate for
Lanxess AG's revenue is
-3%.
The projected
CAGR
for the next 3 years is
3%.